The Effect of Antivascular Endothelial Growth Factor Therapy on the Development of Neovascular Glaucoma after Central Retinal Vein Occlusion: A Retrospective Analysis
Table 2
Ocular characteristics of ischemic and nonischemic CRVO eyes receiving anti-VEGF for macular edema.
Clinical variables
Ischemic ( = 14)
Nonischemic ( = 30)
value
Total follow-up (mos), mean (SD)
23 (7.8)
24 (12.0)
Time between symptom onset and first dose of anti-VEGF (days), mean (SD)